menu
    • menu

    Company profile for Eliem Therapeutics

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eliem is motivated by the promise of helping people live happier, more fulfilling lives. The Eliem team channels its experience, energy and passion for improving patients’ quality of life by developing life-changing novel therapies for neuronal excitability disorders based on clinically validated mechanisms of action.Our two lead drug candidates have clinically validated mechanisms of action for neurological diseases and hav...
    Eliem is motivated by the promise of helping people live happier, more fulfilling lives. The Eliem team channels its experience, energy and passion for improving patients’ quality of life by developing life-changing novel therapies for neuronal excitability disorders based on clinically validated mechanisms of action.Our two lead drug candidates have clinically validated mechanisms of action for neurological diseases and have demonstrated encouraging clinical and preclinical results. We are developing ETX-810 for chronic pain and ETX-155 for major depressive disorder, hormone-related mood disorders and focal onset seizures.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eliem TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    23515 NE Novelty Hill Road, Suite B221 #125 Redmond, WA 98053
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://eliemtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eliemtx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    After an uphill struggle, Eliem fittingly becomes Climb Bio
    After an uphill struggle, Eliem fittingly becomes Climb Bio

    03 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/eliem-therapeutics-mounts-corporate-rebrand-after-pipeline-overhaul-mass-layoffs

    FIERCE PHARMA
    03 Oct 2024
    Share Share
    Eliem Rebrands to Climb Bio, Inc.
    Eliem Rebrands to Climb Bio, Inc.

    02 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//en/news-release/2024/10/02/2957013/0/en/Eliem-Therapeutics-Announces-Rebranding-and-Corporate-Name-Change-to-Climb-Bio-Inc.html

    GLOBENEWSWIRE
    02 Oct 2024
    Share Share
    Eliem Therapeutics To Join Stifel Virtual Immunology And Inflammation Summit
    Eliem Therapeutics To Join Stifel Virtual Immunology And Inflammation Summit

    11 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/11/2944358/0/en/Eliem-Therapeutics-to-Participate-at-the-Stifel-2024-Virtual-Immunology-and-Inflammation-Summit.html

    GLOBENEWSWIRE
    11 Sep 2024
    Share Share
    Eliem Therapeutics Announces Additions to its Leadership Team
    Eliem Therapeutics Announces Additions to its Leadership Team

    26 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/26/2935366/0/en/Eliem-Therapeutics-Announces-Additions-to-its-Leadership-Team.html

    GLOBENEWSWIRE
    26 Aug 2024
    Share Share
    Eliem Therapeutics Reports Second Quarter Financial Results
    Eliem Therapeutics Reports Second Quarter Financial Results

    14 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/14/2929881/0/en/Eliem-Therapeutics-Reports-Second-Quarter-Financial-Results.html

    GLOBENEWSWIRE
    14 Aug 2024
    Share Share
    Eliem Therapeutics Added To Russell 2000® And Russell 3000® Indexes
    Eliem Therapeutics Added To Russell 2000® And Russell 3000® Indexes

    28 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/28/2905768/0/en/Eliem-Therapeutics-Announces-its-Addition-to-the-Russell-2000-and-Russell-3000-Indexes.html

    GLOBENEWSWIRE
    28 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search